Drug Shortage Report for JENTADUETO
| Report ID | 124837 |
| Drug Identification Number | 02403250 |
| Brand name | JENTADUETO |
| Common or Proper name | Jentadueto 2.5/500mg 6x10 |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Market Status | MARKETED |
| Active Ingredient(s) | LINAGLIPTIN METFORMIN HYDROCHLORIDE |
| Strength(s) | 2.5MG 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | Blister Pack 6x10 |
| ATC code | A10BD |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-10-09 |
| Actual start date | 2020-10-13 |
| Estimated end date | 2021-03-01 |
| Actual end date | 2021-02-26 |
| Shortage status | Resolved |
| Updated date | 2021-02-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
| Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2020-10-02 | English | Compare |
| v2 | 2020-09-22 | French | Compare |
| v1 | 2020-09-22 | English | Compare |